We are live on ! Find out more
TEVA icon

Teva Pharmaceuticals
TEVA

744 hedge funds and large institutions have $16.6B invested in Teva Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 744 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.92% more ownership

Funds ownership: 0% → 44.92% (+45%)

11% more call options, than puts

Call options by funds: $268M | Put options by funds: $242M

Holders
744
Holders Change
+744
Holders Change %
–
% of All Funds
24.28%
Holding in Top 10
32
Holding in Top 10 Change
+32
Holding in Top 10 Change %
% of All Funds
1.04%
New
744
Increased
–
Reduced
–
Closed
–
Calls
$268M
Puts
$242M
Net Calls
+$25.9M
Net Calls Change
+$25.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SRC
101
Shufro Rose & Co
New York
$18.8M +$18.7M +479,774 New
OA
102
Oak Associates
Ohio
$18.1M +$18M +462,508 New
Citadel Advisors
103
Citadel Advisors
Florida
$18M +$17.9M +458,669 New
Korea Investment Corp
104
Korea Investment Corp
South Korea
$17.7M +$17.6M +451,500 New
MAA
105
Matrix Asset Advisors
New York
$17.5M +$17.3M +445,259 New
Dimensional Fund Advisors
106
Dimensional Fund Advisors
Texas
$17.1M +$17M +437,398 New
Nomura Asset Management
107
Nomura Asset Management
Japan
$16.6M +$16.5M +424,100 New
PPA
108
Parametric Portfolio Associates
Washington
$16.5M +$16.4M +421,762 New
AIA
109
AGF Investments America
Ontario, Canada
$16.5M +$16.4M +420,153 New
AC
110
Amici Capital
New York
$16.5M +$16.4M +420,000 New
SAM
111
Sectoral Asset Management
Quebec, Canada
$16M +$15.9M +407,749 New
T. Rowe Price Associates
112
T. Rowe Price Associates
Maryland
$15.9M +$15.8M +404,700 New
FMI
113
Factory Mutual Insurance
Massachusetts
$15.7M +$15.6M +399,300 New
SL
114
Summitry LLC
California
$15.5M +$15.4M +396,331 New
Citigroup
115
Citigroup
New York
$15.4M +$15.3M +393,323 New
TD Asset Management
116
TD Asset Management
Ontario, Canada
$14.9M +$14.8M +380,110 New
ST
117
Spot Trading
Illinois
$14.7M +$14.6M +374,604 New
Retirement Systems of Alabama
118
Retirement Systems of Alabama
Alabama
$14.6M +$14.5M +372,000 New
BIM
119
BlackRock Investment Management
Delaware
$14.5M +$14.4M +370,214 New
PDM
120
Penn Davis McFarland
Texas
$14.5M +$14.4M +369,925 New
Neuberger Berman Group
121
Neuberger Berman Group
New York
$14.5M +$14.4M +369,592 New
NFA
122
Nationwide Fund Advisors
Ohio
$14.3M +$14.2M +365,378 New
ACM
123
Accipiter Capital Management
Florida
$14.2M +$14.1M +362,768 New
Capital Fund Management (CFM)
124
Capital Fund Management (CFM)
France
$14.1M +$14M +359,677 New
HPC
125
HM Payson & Co
Maine
$14M +$13.9M +357,079 New
3 4
5
6 7

TEVA Hedge Fund Activity: Q2 2013 in Review

744 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Teva Pharmaceuticals (TEVA) for Q2 2013, worth a combined $16.6B.

Buyers outnumbered sellers: 744 funds opened new TEVA positions and 0 closed out — a net gain of 744 holders — while 0 added to existing stakes and 0 trimmed.

  • 744 institutional investors held Teva Pharmaceuticals (TEVA) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $16.6B of Teva Pharmaceuticals stock for Q2 2013.
  • 744 funds opened new Teva Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +744 holders.

Based on aggregated 13F filings for Q2 2013.